Late incomplete stent apposition after drug-eluting stent implantation: A true risk factor or "an innocent bystander"?

Heart

Volumn 94, Issue 3, 2008, Pages 253-254

  Colombo, Antonio ^a,b   Latib, Azeem ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b EMO GVM CENTRO CUORE COLUMBUS   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

PACLITAXEL; RAPAMYCIN;

ANEURYSM; CLINICAL ASSESSMENT; CLINICAL EVALUATION; DRUG ELUTING STENT; EDITORIAL; FOLLOW UP; HUMAN; HYPERPLASIA; IMPLANTATION; INTIMA; INTRAVASCULAR ULTRASOUND; PRIORITY JOURNAL; RISK FACTOR;

CORONARY THROMBOSIS; DRUG-ELUTING STENTS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; PACLITAXEL; POSTOPERATIVE COMPLICATIONS; PROSTHESIS FAILURE; RISK FACTORS; SIROLIMUS; TIME FACTORS; TUBULIN MODULATORS; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 39749202279     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.2007.126375     Document Type: Editorial

References (12)

1. Hoffmann R, Morice MC, Moses JW, et al. Impact of late incomplete stent apposition after sirolimus-eluting stent implantation on 4-year clinical events. intravascular ultrasound analysis from the multicentre, randomised, RAVEL, E-SIRIUS and SIRIUS Trials. Heart 2007;94:322- 8.
2. Hong MK, Mintz GS, Lee CW, et al. Incidence, mechanism, predictors, and long-term prognosis of late stent malapposition after bare-metal stent implantation. Circulation 2004;109:881-6.
3. Shah VM, Mintz GS, Apple S, et al. Background incidence of late malapposition after bare-metal stent implantation. Circulation 2002;106:1753-5.
4. Joner M, Finn AV, Farb A, et al. Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. J Am Coll Cardiol 2006;48:193-202.
5. Hong MK, Mintz GS, Lee CW, et al. Late stent malapposition after drug-eluting stent implantation: an intravascular ultrasound analysis with long-term follow-up. Circulation 2006;113:414-9.
6. Tanabe K, Serruys FW, Degertekin M, et al. Incomplete stent apposition after implantation of paclitaxel-eluting stents or bare metal stents: insights from the randomized TAXUS II trial. Circulation 2005;111:900-5.
7. Cook S, Wenaweser P, Togni M, et al. Incomplete stent apposition and very late stent thrombosis after drug-eluting stent implantation. Circulation 2007;115:2426-34.
8. Mintz GS. What to do about late incomplete stent apposition? Circulation 2007;115:2379-81.
9. Kimura M, Mintz GS, Carlier S, et al. Outcome after acute incomplete sirolimus-eluting stent apposition as assessed by serial intravascular ultrasound. Am J Cardiol 2006;98:436-42.
10. Ako J, Morino Y, Honda Y, et al. Late incomplete stent apposition after sirolimus-eluting stent implantation: a serial intravascular ultrasound analysis. J Am Coll Cardiol 2005;46:1002-5.
11. Degertekin M, Serruys PW, Tanabe K, et al. Long-term follow-up of incomplete stent apposition in patients who received sirolimus-eluting stent for de novo coronary lesions: an intravascular ultrasound analysis. Circulation 2003;108:2747-50.
12. Siqueira DA, Abizaid AA, Costa JdeR, et al. Late incomplete apposition after drug-eluting stent implantation: incidence and potential for adverse clinical outcomes. Eur Heart J 2007;28:1304-9.